Company / SG&A Expense
NATIONAL HEALTH INVESTORS INC SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$26.9M
FY2025
5-year range
$18.4M / $26.9M
FY2021-FY2025
Trend
+29.6%
vs FY2024
Sector context
#114 of 131
Real Estate
What the data says
NATIONAL HEALTH INVESTORS INC's sg&a expense of $27M is lower than 87% of companies in the Real Estate sector (FY2025). SG&A Expense has fluctuated over the past 10 years, ranging from $10M in FY2016 to $27M in FY2025.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +15.1%.
Increased from $19M to $27M over the past 2 years.
Real Estate sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Real EstateTop 13% of 131This company $26.9M Sector average $159.5M
▼
-83.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 29.6% year-over-year.
- Ranks #114 out of 131 companies in the Real Estate sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 41.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.9M | +29.6% |
| FY2024 | $20.7M | +7.4% |
| FY2023 | $19.3M | -15.2% |
| FY2022 | $22.8M | +23.5% |
| FY2021 | $18.4M | +38.5% |
| FY2020 | $13.3M | -0.7% |
| FY2019 | $13.4M | +6.8% |
| FY2018 | $12.5M | +2.7% |
| FY2017 | $12.2M | +25.0% |
| FY2016 | $9.8M | -7.1% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026